A. T. McLellan, “Have we evaluated addiction treatment correctly? Implications from a chronic care perspective,” Addiction, vol. 97, no. 3, pp. 249–252, 2002.
 A. T. McLellan, J. R. McKay, R. Forman, J. Cacciola, and J. Kemp, “Reconsidering the evaluation of addiction treatment: from retrospective follow‐up to concurrent recovery monitoring,” Addiction, vol. 100, no. 4, pp. 447–458, 2005.
 W. White, Recovery management and recovery-oriented systems of care, vol. 6. Chicago: Great Lakes Addiction Technology Transfer Center, Northeast …, 2008.
 G. De Leon, The therapeutic community: Theory, model, and method. Springer Publishing Company, 2000.
 G. Adshead, “Security and the social mind: Attachment and therapeutic communities,” Ther. Communities Int. J. Ther. Communities, 2015.
 D. Veale, P. Gilbert, J. Wheatley, and I. Naismith, “A new therapeutic community: Development of a compassion‐focussed and contextual behavioural environment,” Clin. Psychol. Psychother., vol. 22, no. 4, pp. 285–303, 2015.
 L. Magor-blatch, N. Bhullar, B. Thomson, and E. Thorsteinsson, “A systematic review of studies examining effectiveness of therapeutic communities,” 2014.
 P. K. Staiger, P. Liknaitzky, A. J. Lake, and S. Gruenert, “Longitudinal Substance Use and Biopsychosocial Outcomes Following Therapeutic Community Treatment for Substance Dependence,” J. Clin. Med., vol. 9, no. 1, p. 118, 2020.
 W. Vanderplasschen et al., “Therapeutic communities for addictions : a review of their effectiveness from a recovery- oriented perspective ( Greek version ). Therapeutic Communities for Addictions : A Review of Their Effectiveness from a Recovery-Oriented Perspective,” no. September 2016, 2014.
 M. Malivert, “Effectiveness of Therapeutic Communities :,” pp. 1–11, 2012.
 R. M. Etheridge, S. G. Craddock, G. H. Dunteman, and R. L. Hubbard, “Treatment services in two national studies of community-based drug abuse treatment programs,” J. Subst. Abuse, vol. 7, no. 1, pp. 9–26, 1995.
 M. Gossop, J. Marsden, D. Stewart, and A. Rolfe, “Treatment retention and 1 year outcomes for residential programmes in England,” vol. 57, pp. 89–98, 1999.
 D. D. Simpson and S. B. Sells, “Effectiveness of treatment for drug abuse: An overview of the DARP research program,” Adv. Alcohol Subst. Abuse, vol. 2, no. 1, pp. 7–29, 1982.
 A. Jones et al., “The Drug Treatment Outcomes Research Study (DTORS): Final outcomes report,” Londres Home Off. Recuper. http//www. dtors. org. uk/reports/DTORS_Final_Main. pdf, 2009.
 J. R. McKay, “Continuing care research: What we have learned and where we are going,” J. Subst. Abuse Treat., vol. 36, no. 2, pp. 131–145, 2009.
 Y.-I. Hser, M. D. Anglin, and B. Fletcher, “Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction,” J. Subst. Abuse Treat., vol. 15, no. 6, pp. 513–523, 1998.
 R. L. Hubbard, J. V Rachal, and S. G. Craddock, “Treatment outcome prospective study (TOPS): client characteristics before, during, and after treatment” Washingt. NIDA, 1984.
 S. Darke, J. Ross, K. L. Mills, A. Williamson, A. Havard, and M. Teesson, “Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS),” Addict. Behav., vol. 32, no. 9, pp. 1897–1906, 2007.
 B. J. Rounsaville, M. M. Weissman, K. Crits-Christoph, C. Wilber, and H. Kleber, “Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome,” Arch. Gen. Psychiatry, vol. 39, no. 2, pp. 151–156, 1982.
 R. P. Mattick, S. O’Brien, and J. Dodding, Outcome evaluation of the Woolshed Program. National Drug and Alcohol Research Centre, University of New South Wales, 1998.
 R. H. Coombs, “Back on the streets: Therapeutic communities’ impact upon drug users,” Am. J. Drug Alcohol Abuse, vol. 8, no. 2, pp. 185–201, 1981.
 M. L. Hiller, K. Knight, and D. D. Simpson, “Prison‐based substance abuse treatment, residential aftercare and recidivism,” Addiction, vol. 94, no. 6, pp. 833–842, 1999.
 N. Vidjak, “Treating heroin addiction: Comparison of methadone therapy, hospital therapy without methadone, and therapeutic community,” Croat. Med. J., vol. 44, no. 1, pp. 59–64, 2002.
 S. Darke, G. Campbell, and G. Popple, “Retention, early dropout and treatment completion among therapeutic community admissions,” Drug Alcohol Rev., vol. 31, no. 1, pp. 64–71, 2012.
 C. Perryman, G. A. Dingle, C. Perryman, and G. Dingle, “A systematic review of the methodologies used in research related to adult drug and alcohol rehabilitation in therapeutic communities,” no. September 2016, 2015.
 D. D. Simpson, G. W. Joe, K. M. Broome, M. L. Hiller, K. Knight, and G. A. Rowan-Szal, “Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS).,” Psychol. Addict. Behav., vol. 11, no. 4, p. 279, 1997.
 N. D. Volkow, Principles of drug addiction treatment: A research-based guide, vol. 12, no. 4180. DIANE Publishing, 2011.
 J. J. López-goñi, J. Fernández-, C. Illescas, and N. Landa, “Determining socio-demographic predictors of treatment dropout : results in a therapeutic community,” no. 2006, pp. 374–378, 2008.
 K. J. Brower, F. C. Blow, E. M. Hill, and S. A. Mudd, “Treatment outcome of alcoholics with and without cocaine disorders,” Alcohol. Clin. Exp. Res., vol. 18, no. 3, pp. 734–739, 1994.
 R. E. Claus, L. R. Kindleberger, and M. C. Dugan, “Predictors of attrition in a longitudinal study of substance abusers,” J. Psychoactive Drugs, vol. 34, no. 1, pp. 69–74, 2002.
 R. R. Gainey, E. A. Wells, J. D. Hawkins, and R. F. Catalano, “Predicting treatment retention among cocaine users,” Int. J. Addict., vol. 28, no. 6, pp. 487–505, 1993.
 J. R. McKAY, A. T. McLELLAN, A. I. Alterman, J. S. Cacciola, M. J. Rutherford, and C. P. O’Brien, “Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse.,” J. Stud. Alcohol, vol. 59, no. 2, pp. 152–162, 1998.
 N. Sadir, M. Shojaei, K. Moadab, R. Abbasi, and A. Bahrampour, “Outcome Evaluation of Therapeutic Community Model in Iran,” vol. 1, no. 2, pp. 131–135, 2013.
 W. N. Welsh and P. N. McGrain, “Predictors of therapeutic engagement in prison-based drug treatment,” Drug Alcohol Depend., vol. 96, no. 3, pp. 271–280, 2008.
 R. T. Mulder, C. M. A. FRAMPTON, H. Peka, G. Hampton, and T. Marsters, “Predictors of 3‐month retention in a drug treatment therapeutic community,” Drug Alcohol Rev., vol. 28, no. 4, pp. 366–371, 2009.
 K. Knight, M. L. Hiller, K. M. Broome, and D. D. Simpson, “Legal pressure, treatment readiness, and engagement in long-term residential programs,” J. Offender Rehabil., vol. 31, no. 1–2, pp. 101–115, 2000.
 M. L. Hiller, K. Knight, C. Leukefeld, and D. D. Simpson, “Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment,” Crim. Justice Behav., vol. 29, no. 1, pp. 56–75, 2002.
 P. S. Meier and D. Best, “Programme factors that influence completion of residential treatment,” no. July, pp. 349–355, 2006.
 A. T. Alshomrani, A. T. Khoja, S. F. Alseraihah, and M. A. Mahmoud, “Drug use patterns and demographic correlations of residents of Saudi therapeutic communities for addiction,” J. Taibah Univ. Med. Sci., vol. 12, no. 4, pp. 304–312, 2017.
 A. T. Alshomrani, “Saudi addiction therapeutic communities: Are they implementing the essential elements of addiction therapeutic communities?,” Neurosciences, vol. 21, no. 3, pp. 227–231, 2016.
 P. B. Practice, “Towards Better Practice in Therapeutic Communities P. B. Practice, ‘Towards Better Practice in Therapeutic Communities.’”
 J. Keen, P. Oliver, G. Rowse, and N. Mathers, “Residential rehabilitation for drug users: a review of 13 months’ intake to a therapeutic community,” Fam. Pract., vol. 18, no. 5, pp. 545–548, 2001.
 M. Maglione, B. Chao, and D. Anglin, “Residential treatment of methamphetamine users: Correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994–1997,” Addict. Res., vol. 8, no. 1, pp. 65–79, 2000.